Page 46 - SPONDYLOARTHRITIS IN COLOMBIA -

24 Valle-Oñate R, Candia L, Romero Sánchez C, et al. Epidemiology of Spondyloarthritis in Colombia Am J Med Sci 2011;341:293-4
25 Londoño J, González L, Ramírez A, et al. Caracterización de las espondiloartropatías y determinación de factores de mal pronóstico en una población de pacientes colombianos. Rev Colomb Reumatol 2005; 12:195–207
26 Márquez J, Pinto L, Candia D. Hospital Pablo Tobón Uribe-Spondyloarthropathies. A cohort description. Rev Colomb Reumatol 2010;17:80-85
27 Burgos-Vargas R, Naranjo A, Castillo J, et al. Ankylosing spondylitis in the Mexican mestizo: Patterns of disease according to age at onset J Rheumatol 1989;16:186-91
28 Carneiro S, Bortoluzzo AB, Gonçalves CR, et al. Effect of enthesitis on 1505 Brazilian patients with spondyloarthritis. J Rheumatol. 2013;40:1719–25
29 Benegas M, Muñoz-Gomariz E, Font P. Comparison of the clinical expression of patients with ankylosing spondylitis from Europe and Latin America. J Rheumatol 2012;39:2315-20
30 Rudwaleit M, Haibel H, Baraliakos X, et al. The early disease stage in axial spondyloarthritis. Results from the German Spondyloarthritis Inception Cohort. Arthritis Rheum 2009; 60:717–727
31 Khan MA. HLA-B27 and its subtypes in world populations. Curr Opin Rheumatol. 1995;7:263–9
32 Arellano J, Vallejo M, Jimenez J, et al. HLA-B27 and ankylosing spondylitis in the Mexican Mestizo population.
Tissue Antigens 1984;23:112-8.
33 Londoño J, Santos AM, Peña P, Calvo E, Espinosa LR, Reveille JD, et al. Analysis of HLA-B15 and HLA-B27 in
spondyloarthritis with peripheral and axial clinical patterns. BMJ Open. 2015;5(11):e009092
44